Melbourne-based biotech Telix Pharmaceuticals has announced that its prostate cancer diagnostic agent Illuccix has been ...

Announced sale of FibroGen China to AstraZeneca for a total consideration of approximately $160 millionTransaction expected to close by ...

Saikali S, Khosravi P, Gamal A, et al. MP07-02 Detection of Prostate Cancer Extracapsular Extension with MRI Using Deep Learning Methods. J Urol. 2024 May;211 (5S):e105.

Educating physicians about PSA reduction goals may increase the number of patients with mCSPC receiving first-line treatment ...

A former Dunfermline High School pupil has been celebrated for her outstanding research in the field of cancer studies.

Mateship, support, information: this and more are what two cancer survivors are hopeful a dedicated prostate cancer nurse can ...

Eurolab has achieved a landmark legal victory in South Africa, allowing the company to produce and sell a generic version of ...

The first patient has been enrolled in the PROSTATE-IQ trial of ArteraAI, a multimodal artificial intelligence biomarker test ...

Currently, doctors usually check PSA levels about six to eight weeks after surgery. However, a new study from Mass General ...

Scott Eggener, MD, gave a talk at the LUGPA annual meeting titled “Leveraging Cutting-Edge Technologies to Enhance Prostate Cancer Treatments.” ...

Recently announced positive data from pivotal randomized, placebo-controlled phase 3 clinical trial of CAN-2409 in intermediate-to-high risk, ...

Erectile dysfunction is common after prostate cancer treatment. A new study shows that aerobic exercise and strength training ...